search
Back to results

Staying Active With Arthritis: RCT of Physical Activity for Older Adults With Osteoarthritis and Hypertension (STAR)

Primary Purpose

Osteoarthritis, Knee, Hypertension

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
STAR Intervention
Attention-Control
Sponsored by
University of Pittsburgh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis, Knee focused on measuring Osteoarthritis, Knee, Hypertension, Exercise, Physical activity, Self Efficacy, Patient Compliance, Aged

Eligibility Criteria

50 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 50 years or older.
  • Is community dwelling.
  • Has osteoarthritis of the knee.
  • Has hypertension for which monotherapy or combination pharmacological treatment is prescribed.
  • Able to complete a behavioral run-in consisting of completing questionnaires, using a 7-day electronic-diary, and wearing an ActiGraph accelerometer at the waist for 7 days.
  • Has written permission to participate from the physician.

Exclusion Criteria:

  • Reports currently doing lower extremity exercise => 2 times/week.
  • Reports currently fitness walking => 90 minutes/week.
  • Incapable of managing their own treatment regimen.
  • Does not have, or cannot use, a telephone or is unwilling to provide a telephone number.
  • Has received cortisone or Synvisc injections in the knee, angioplasty, stents, or a pacemaker in the past 6 months.
  • Reports unstable cardiovascular, pulmonary, or metabolic disease or signs and symptoms suggestive of cardiovascular, pulmonary, or metabolic disease that restrict activity.
  • Has resting systolic blood pressure => 160 mm Hg or diastolic blood pressure => 100 mm Hg.
  • Reports other conditions, such as osteoarthritis of the hip, spinal stenosis, inflammatory arthritis, foot drop, diabetes treated with insulin, or diabetic complications that may affect performance of lower extremity exercise and participation in fitness walking.
  • Reports current knee conditions, such as meniscus tears and knee ligament ruptures.
  • Reports major depression that may impact the ability to fully participate in this study.
  • Is scheduled to undergo a major surgical procedure in the next 13 months.
  • Is concurrently participating in a drug or psychoeducational trial that may confound, or be confounded by, participation in this study.

Sites / Locations

  • University of Pittsburgh School of Nursing

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

STAR Intervention

Attention-Control

Arm Description

Staying Active with Arthritis Intervention

Senior Health Information Intervention

Outcomes

Primary Outcome Measures

Performance of Lower Extremity Exercise at 25 Weeks
Measured by the electronic-diary in terms of the total volume of lower extremity exercise (i.e., the number of days the participant reports completing a lower extremity exercise session and the total number of lower extremity exercises per day performed [repetitions x sets] over a 7-day period).
Participation in Fitness Walking at 25 Weeks
Measured by the ActiGraph accelerometer in terms of mean daily activity minutes of none to very low, light, and moderate-to-vigorous activity counts summarized over a 7-day period.
Objective Functional Status by the 6-minute Walk at 25 Weeks
Measured by the 6-minute walk (yards) as part of the performance-based functional status assessment.
Objective Functional Status by the Short Physical Performance Battery at 25 Weeks
Measured by the Short Physical Performance Battery (total scale score) as part of the performance-based functional status assessment; subscale scores are summed for a total scale score; the scale score range is 0-13; higher scores are better.
Systolic Blood Pressure at 25 Weeks
Measured by the OMRON HEM-907XL automatic professional digital blood pressure monitor in mm Hg.
Diastolic Blood Pressure at 25 Weeks
Measured by the OMRON HEM-907XL automatic professional digital blood pressure monitor in mm Hg.
Performance of Lower Extremity Exercise at 52 Weeks
Measured by the electronic-diary in terms of the total volume of lower extremity exercise (i.e., the number of days the subject reports completing a lower extremity exercise session and the total number of lower extremity exercises per day performed [repetitions x sets] over a 7-day period).
Participation in Fitness Walking at 52 Weeks
Measured by the ActiGraph accelerometer in terms of mean daily activity minutes of none to very low, light, and moderate-to-vigorous activity counts summarized over a 7-day period.
Objective Functional Status by the 6-minute Walk at 52 Weeks
Measured by the 6-minute walk (yards) as part of the performance-based functional status assessment.
Objective Functional Status by the Short Physical Performance Battery at 52 Weeks
Measured by the Short Physical Performance Battery (total scale score) as part of the performance-based functional status assessment; subscale scores are summed for a total scale score; the scale score range is 0-13; higher scores are better.
Systolic Blood Pressure at 52 Weeks
Measured by the OMRON HEM-907XL automatic professional digital blood pressure monitor in mm Hg.
Diastolic Blood Pressure at 52 Weeks
Measured by the OMRON HEM-907XL automatic professional digital blood pressure monitor in mm Hg.

Secondary Outcome Measures

Subjective Functional Status at 25 Weeks
Measured by the Physical Function subscale of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index; the subscale score range is 0-68; lower scores are better.
Quadriceps Strength at 25 Weeks
Measured by the MicroFET2 hand-held dynamometer in terms of mean maximum pounds over two trials.
Pain by the Pain Subscale of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index at 25 Weeks
Measured by the Pain subscale of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index; the subscale score range is 0-20; lower scores are better.
Pain by the Bodily Pain Subscale of the Short Form-36v2 at 25 Weeks
Measured by the Bodily Pain subscale of the Short Form-36v2; the subscale score range is 0-100; higher scores are better.
Fatigue at 25 Weeks
Measured by the Brief Fatigue Inventory, which assesses fatigue severity; the scale score range is 0-10; lower scores are better.
Health-Related Quality of Life at 25 Weeks
Measured by the Short Form-36v2 in terms of the following: Mental Component: this summary scale is composed of eight subscale scores primarily derived from the mental health, role functioning-emotional, and social functioning scores; the scale score range is 0-100; higher scores are better Physical Component: this summary scale is composed of eight subscale scores primarily derived from the physical functioning, role functioning-physical, and bodily pain scores; the scale score range is 0-100; higher scores are better
Self-Efficacy at 25 Weeks
Measured by the Self-Efficacy Scale in terms of the following: Exercise Barriers Self-Efficacy subscale: the subscale score range is 0-100; higher scores are better Exercise Self-Efficacy subscale: the subscale score range is 0-100; higher scores are better
Arthritis Self-Efficacy at 25 Weeks
Measured by the Arthritis Self-Efficacy Scale in terms of the following: Pain subscale: the subscale score range is 10-100; higher scores are better Function subscale: the subscale score range is 10-100; higher scores are better Other Symptoms subscale: the subscale score range is 10-100; higher scores are better
Outcome Expectancy at 25 Weeks
Measured by the Perceived Therapeutic Efficacy Scale in terms of the following: Exercise and Arthritis: the scale score range is 0-100; higher scores are better Exercise and Hypertension: the scale score range is 0-100; higher scores are better
Subjective Functional Status at 52 Weeks
Measured by the Physical Function subscale of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index; the subscale score range is 0-68; lower scores are better.
Quadriceps Strength at 52 Weeks
Measured by the MicroFET2 hand-held dynamometer in terms of mean maximum pounds over two trials.
Pain by the Pain Subscale of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index at 52 Weeks
Measured by the Pain subscale of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index; the subscale score range is 0-20; lower scores are better.
Pain by the Bodily Pain Subscale of the Short Form-36v2 at 52 Weeks
Measured by the Bodily Pain subscale of the Short Form-36v2; the subscale score range is 0-100; higher scores are better.
Fatigue at 52 Weeks
Measured by the Brief Fatigue Inventory, which assesses fatigue severity; the scale score range is 0-10; lower scores are better.
Health-Related Quality of Life at 52 Weeks
Measured by the Short Form-36v2 in terms of the following: Mental Component: this summary scale is composed of eight subscale scores primarily derived from the mental health, role functioning-emotional, and social functioning scores; the scale score range is 0-100; higher scores are better Physical Component: this summary scale is composed of eight subscale scores primarily derived from the physical functioning, role functioning-physical, and bodily pain scores; the scale score range is 0-100; higher scores are better
Self-Efficacy at 52 Weeks
Measured by the Self-Efficacy Scale in terms of the following: Exercise Barriers Self-Efficacy subscale: the subscale score range is 0-100; higher scores are better Exercise Self-Efficacy subscale: the subscale score range is 0-100; higher scores are better
Arthritis Self-Efficacy at 52 Weeks
Measured by the Arthritis Self-Efficacy Scale in terms of the following: Pain subscale: the subscale score range is 10-100; higher scores are better Function subscale: the subscale score range is 10-100; higher scores are better Other Symptoms subscale: the subscale score range is 10-100; higher scores are better
Outcome Expectancy at 52 Weeks
Measured by the Perceived Therapeutic Efficacy Scale in terms of the following: Exercise and Arthritis: the scale score range is 0-100; higher scores are better Exercise and Hypertension: the scale score range is 0-100; higher scores are better

Full Information

First Posted
December 17, 2010
Last Updated
January 2, 2018
Sponsor
University of Pittsburgh
Collaborators
National Institute of Nursing Research (NINR)
search

1. Study Identification

Unique Protocol Identification Number
NCT01280903
Brief Title
Staying Active With Arthritis: RCT of Physical Activity for Older Adults With Osteoarthritis and Hypertension
Acronym
STAR
Official Title
Promoting Physical Activity in Older Adults With Comorbidity
Study Type
Interventional

2. Study Status

Record Verification Date
January 2018
Overall Recruitment Status
Completed
Study Start Date
January 2012 (undefined)
Primary Completion Date
April 2015 (Actual)
Study Completion Date
April 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pittsburgh
Collaborators
National Institute of Nursing Research (NINR)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of the Staying Active with Arthritis (STAR) research study is to determine if a 6-month program will improve leg exercise, fitness walking, and clinical outcomes (function, blood pressure, leg strength, pain, fatigue, and health-related quality of life) in older adults with osteoarthritis of the knee and high blood pressure.
Detailed Description
Over 9 million Americans have symptomatic osteoarthritis (OA) of the knee, a chronic disease associated with frequent joint pain, functional limitations, and quadriceps weakness that intrude upon everyday life. At least half of those with OA of the knee are diagnosed with hypertension or high blood pressure (HBP), one of the most prevalent risk factors for cardiovascular disease. Many other individuals with OA of the knee unknowingly have HBP and remain untreated. Our own work and that of others suggest that persons with OA of the knee experience reductions in BP when they participate in a regular regimen of physical activity. Even small decreases in systolic and diastolic BP found with physical activity are clinically significant, e.g., a 2 mm Hg decrease reduces the risk of stroke by 14% - 17%, and the risk of coronary heart disease is reduced by 6% - 9%. Yet, only 15% of persons with OA and 47% with HBP engage in regular physical activity. The purpose of this study is to investigate how the individually delivered, home-based, 6-month modified Staying Active with Arthritis (STAR) intervention, guided by self-efficacy theory and modified to address comorbid HBP, affects lower extremity exercise (flexibility, strengthening, and balance), fitness walking, functional status, BP, quadriceps strength, pain, fatigue, and health-related quality of life (HRQoL) in a convenience sample of 224 adults age 50 years or older with OA of the knee and HBP. Using a randomized controlled, 2-group design, we (1) hypothesize that at the end of the 6-month intervention period and 6 months after the intervention period ends those who receive the modified STAR intervention will be more likely to perform lower extremity exercise, participate in fitness walking, show improvements in objective functional status, and demonstrate reductions in BP than those who receive attention-control. Secondarily, we will (2) evaluate the impact of the modified STAR intervention, compared to attention-control, on subjective functional status, quadriceps strength, pain, fatigue, and HRQoL at both time points; (3) explore the impact of the modified STAR intervention, compared to attention-control, on self-efficacy and outcome expectancy at both time points; (4) explore the relationship between self-efficacy and outcome expectancy; and (5) explore the extent to which self-efficacy and outcome expectancy mediate the relationship between the modified STAR intervention and performance of lower extremity exercise and participation in fitness walking. Data will be analyzed using repeated measures modeling.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Knee, Hypertension
Keywords
Osteoarthritis, Knee, Hypertension, Exercise, Physical activity, Self Efficacy, Patient Compliance, Aged

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
182 (Actual)

8. Arms, Groups, and Interventions

Arm Title
STAR Intervention
Arm Type
Experimental
Arm Description
Staying Active with Arthritis Intervention
Arm Title
Attention-Control
Arm Type
Placebo Comparator
Arm Description
Senior Health Information Intervention
Intervention Type
Behavioral
Intervention Name(s)
STAR Intervention
Intervention Description
The 24-week modified Staying Active with Arthritis (STAR) intervention, guided by self-efficacy theory and modified to address comorbid hypertension, consists of 6 weekly individual face-to-face exercise sessions by a licensed physical therapist, 9 biweekly telephone counseling sessions by a registered nurse to continue the use of self-efficacy strategies, and lower extremity exercise and fitness walking being carried out at home between sessions. There will be no contact with participants during weeks 7, 9, 11, 13, 15, 17, 19, 21, and 23. During the 6-month follow-up period, the participants will be contacted briefly by telephone by a registered nurse at weeks 30, 36, and 48 for a general check-up.
Intervention Type
Behavioral
Intervention Name(s)
Attention-Control
Intervention Description
Attention-Control is a 24-week general health education program for older adults that consists of 6 weekly telephone sessions by a registered nurse followed by 9 biweekly telephone sessions by a registered nurse. There will be no contact with participants during weeks 7, 9, 11, 13, 15, 17, 19, 21, and 23. Topics include cancer screenings; immunizations; osteoporosis; low vision; hearing loss; talking with your primary care provider; eating healthy (two parts); sleep and aging; injury prevention (two parts: balance problems and falls); oral health; foot care; and mental health (depression). During the 6-month follow-up period, the participants will be contacted briefly by telephone by a registered nurse at weeks 30, 36, and 48 for a general check-up.
Primary Outcome Measure Information:
Title
Performance of Lower Extremity Exercise at 25 Weeks
Description
Measured by the electronic-diary in terms of the total volume of lower extremity exercise (i.e., the number of days the participant reports completing a lower extremity exercise session and the total number of lower extremity exercises per day performed [repetitions x sets] over a 7-day period).
Time Frame
At the end of the 6-month intervention period (week 25)
Title
Participation in Fitness Walking at 25 Weeks
Description
Measured by the ActiGraph accelerometer in terms of mean daily activity minutes of none to very low, light, and moderate-to-vigorous activity counts summarized over a 7-day period.
Time Frame
At the end of the 6-month intervention period (week 25)
Title
Objective Functional Status by the 6-minute Walk at 25 Weeks
Description
Measured by the 6-minute walk (yards) as part of the performance-based functional status assessment.
Time Frame
At the end of the 6-month intervention period (week 25)
Title
Objective Functional Status by the Short Physical Performance Battery at 25 Weeks
Description
Measured by the Short Physical Performance Battery (total scale score) as part of the performance-based functional status assessment; subscale scores are summed for a total scale score; the scale score range is 0-13; higher scores are better.
Time Frame
At the end of the 6-month intervention period (week 25)
Title
Systolic Blood Pressure at 25 Weeks
Description
Measured by the OMRON HEM-907XL automatic professional digital blood pressure monitor in mm Hg.
Time Frame
At the end of the 6-month intervention period (week 25)
Title
Diastolic Blood Pressure at 25 Weeks
Description
Measured by the OMRON HEM-907XL automatic professional digital blood pressure monitor in mm Hg.
Time Frame
At the end of the 6-month intervention period (week 25)
Title
Performance of Lower Extremity Exercise at 52 Weeks
Description
Measured by the electronic-diary in terms of the total volume of lower extremity exercise (i.e., the number of days the subject reports completing a lower extremity exercise session and the total number of lower extremity exercises per day performed [repetitions x sets] over a 7-day period).
Time Frame
6 months after the intervention period ends (week 52)
Title
Participation in Fitness Walking at 52 Weeks
Description
Measured by the ActiGraph accelerometer in terms of mean daily activity minutes of none to very low, light, and moderate-to-vigorous activity counts summarized over a 7-day period.
Time Frame
6 months after the intervention period ends (week 52)
Title
Objective Functional Status by the 6-minute Walk at 52 Weeks
Description
Measured by the 6-minute walk (yards) as part of the performance-based functional status assessment.
Time Frame
6 months after the intervention period ends (week 52)
Title
Objective Functional Status by the Short Physical Performance Battery at 52 Weeks
Description
Measured by the Short Physical Performance Battery (total scale score) as part of the performance-based functional status assessment; subscale scores are summed for a total scale score; the scale score range is 0-13; higher scores are better.
Time Frame
6 months after the intervention period ends (week 52)
Title
Systolic Blood Pressure at 52 Weeks
Description
Measured by the OMRON HEM-907XL automatic professional digital blood pressure monitor in mm Hg.
Time Frame
6 months after the intervention period ends (week 52)
Title
Diastolic Blood Pressure at 52 Weeks
Description
Measured by the OMRON HEM-907XL automatic professional digital blood pressure monitor in mm Hg.
Time Frame
6 months after the intervention period ends (week 52)
Secondary Outcome Measure Information:
Title
Subjective Functional Status at 25 Weeks
Description
Measured by the Physical Function subscale of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index; the subscale score range is 0-68; lower scores are better.
Time Frame
At the end of the 6-month intervention period (week 25)
Title
Quadriceps Strength at 25 Weeks
Description
Measured by the MicroFET2 hand-held dynamometer in terms of mean maximum pounds over two trials.
Time Frame
At the end of the 6-month intervention period (week 25)
Title
Pain by the Pain Subscale of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index at 25 Weeks
Description
Measured by the Pain subscale of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index; the subscale score range is 0-20; lower scores are better.
Time Frame
At the end of the 6-month intervention period (week 25)
Title
Pain by the Bodily Pain Subscale of the Short Form-36v2 at 25 Weeks
Description
Measured by the Bodily Pain subscale of the Short Form-36v2; the subscale score range is 0-100; higher scores are better.
Time Frame
At the end of the 6-month intervention period (week 25)
Title
Fatigue at 25 Weeks
Description
Measured by the Brief Fatigue Inventory, which assesses fatigue severity; the scale score range is 0-10; lower scores are better.
Time Frame
At the end of the 6-month intervention period (week 25)
Title
Health-Related Quality of Life at 25 Weeks
Description
Measured by the Short Form-36v2 in terms of the following: Mental Component: this summary scale is composed of eight subscale scores primarily derived from the mental health, role functioning-emotional, and social functioning scores; the scale score range is 0-100; higher scores are better Physical Component: this summary scale is composed of eight subscale scores primarily derived from the physical functioning, role functioning-physical, and bodily pain scores; the scale score range is 0-100; higher scores are better
Time Frame
At the end of the 6-month intervention period (week 25)
Title
Self-Efficacy at 25 Weeks
Description
Measured by the Self-Efficacy Scale in terms of the following: Exercise Barriers Self-Efficacy subscale: the subscale score range is 0-100; higher scores are better Exercise Self-Efficacy subscale: the subscale score range is 0-100; higher scores are better
Time Frame
At the end of the 6-month intervention period (week 25)
Title
Arthritis Self-Efficacy at 25 Weeks
Description
Measured by the Arthritis Self-Efficacy Scale in terms of the following: Pain subscale: the subscale score range is 10-100; higher scores are better Function subscale: the subscale score range is 10-100; higher scores are better Other Symptoms subscale: the subscale score range is 10-100; higher scores are better
Time Frame
At the end of the 6-month intervention period (week 25)
Title
Outcome Expectancy at 25 Weeks
Description
Measured by the Perceived Therapeutic Efficacy Scale in terms of the following: Exercise and Arthritis: the scale score range is 0-100; higher scores are better Exercise and Hypertension: the scale score range is 0-100; higher scores are better
Time Frame
At the end of the 6-month intervention period (week 25)
Title
Subjective Functional Status at 52 Weeks
Description
Measured by the Physical Function subscale of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index; the subscale score range is 0-68; lower scores are better.
Time Frame
6 months after the intervention period ends (week 52)
Title
Quadriceps Strength at 52 Weeks
Description
Measured by the MicroFET2 hand-held dynamometer in terms of mean maximum pounds over two trials.
Time Frame
6 months after the intervention period ends (week 52)
Title
Pain by the Pain Subscale of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index at 52 Weeks
Description
Measured by the Pain subscale of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index; the subscale score range is 0-20; lower scores are better.
Time Frame
6 months after the intervention period ends (week 52)
Title
Pain by the Bodily Pain Subscale of the Short Form-36v2 at 52 Weeks
Description
Measured by the Bodily Pain subscale of the Short Form-36v2; the subscale score range is 0-100; higher scores are better.
Time Frame
6 months after the intervention period ends (week 52)
Title
Fatigue at 52 Weeks
Description
Measured by the Brief Fatigue Inventory, which assesses fatigue severity; the scale score range is 0-10; lower scores are better.
Time Frame
6 months after the intervention period ends (week 52)
Title
Health-Related Quality of Life at 52 Weeks
Description
Measured by the Short Form-36v2 in terms of the following: Mental Component: this summary scale is composed of eight subscale scores primarily derived from the mental health, role functioning-emotional, and social functioning scores; the scale score range is 0-100; higher scores are better Physical Component: this summary scale is composed of eight subscale scores primarily derived from the physical functioning, role functioning-physical, and bodily pain scores; the scale score range is 0-100; higher scores are better
Time Frame
6 months after the intervention period ends (week 52)
Title
Self-Efficacy at 52 Weeks
Description
Measured by the Self-Efficacy Scale in terms of the following: Exercise Barriers Self-Efficacy subscale: the subscale score range is 0-100; higher scores are better Exercise Self-Efficacy subscale: the subscale score range is 0-100; higher scores are better
Time Frame
6 months after the intervention period ends (week 52)
Title
Arthritis Self-Efficacy at 52 Weeks
Description
Measured by the Arthritis Self-Efficacy Scale in terms of the following: Pain subscale: the subscale score range is 10-100; higher scores are better Function subscale: the subscale score range is 10-100; higher scores are better Other Symptoms subscale: the subscale score range is 10-100; higher scores are better
Time Frame
6 months after the intervention period ends (week 52)
Title
Outcome Expectancy at 52 Weeks
Description
Measured by the Perceived Therapeutic Efficacy Scale in terms of the following: Exercise and Arthritis: the scale score range is 0-100; higher scores are better Exercise and Hypertension: the scale score range is 0-100; higher scores are better
Time Frame
6 months after the intervention period ends (week 52)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 50 years or older. Is community dwelling. Has osteoarthritis of the knee. Has hypertension for which monotherapy or combination pharmacological treatment is prescribed. Able to complete a behavioral run-in consisting of completing questionnaires, using a 7-day electronic-diary, and wearing an ActiGraph accelerometer at the waist for 7 days. Has written permission to participate from the physician. Exclusion Criteria: Reports currently doing lower extremity exercise => 2 times/week. Reports currently fitness walking => 90 minutes/week. Incapable of managing their own treatment regimen. Does not have, or cannot use, a telephone or is unwilling to provide a telephone number. Has received cortisone or Synvisc injections in the knee, angioplasty, stents, or a pacemaker in the past 6 months. Reports unstable cardiovascular, pulmonary, or metabolic disease or signs and symptoms suggestive of cardiovascular, pulmonary, or metabolic disease that restrict activity. Has resting systolic blood pressure => 160 mm Hg or diastolic blood pressure => 100 mm Hg. Reports other conditions, such as osteoarthritis of the hip, spinal stenosis, inflammatory arthritis, foot drop, diabetes treated with insulin, or diabetic complications that may affect performance of lower extremity exercise and participation in fitness walking. Reports current knee conditions, such as meniscus tears and knee ligament ruptures. Reports major depression that may impact the ability to fully participate in this study. Is scheduled to undergo a major surgical procedure in the next 13 months. Is concurrently participating in a drug or psychoeducational trial that may confound, or be confounded by, participation in this study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elizabeth A. Schlenk, PhD, RN
Organizational Affiliation
University of Pittsburgh
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pittsburgh School of Nursing
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15261
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33039202
Citation
Schlenk EA, Sereika SM, Martire LM, Shi X. Older adults' social network and support and its association with physical activity. Geriatr Nurs. 2021 Mar-Apr;42(2):517-523. doi: 10.1016/j.gerinurse.2020.09.006. Epub 2020 Oct 7.
Results Reference
derived

Learn more about this trial

Staying Active With Arthritis: RCT of Physical Activity for Older Adults With Osteoarthritis and Hypertension

We'll reach out to this number within 24 hrs